Cursor, the AI-powered code editor built on VS Code, has achieved what may be the most remarkable revenue efficiency milestone in software history: $500M in annual recurring revenue with approximately 140 employees. That's $3.6M of ARR per employee — significantly higher than even the most efficient SaaS businesses have managed at this scale.
What this means for equity
At a $9B Series B valuation with 140 employees, the implied enterprise value per employee is approximately $64M. Even accounting for preferred stack, option dilution, and the fact that many employees hold a small fraction of a percent, the equity concentration is extraordinary. Founding team members and early employees likely hold positions worth tens of millions of dollars.
The secondary market view
Hiive shows trades implying a $12B valuation for Cursor as of March 2026 — a 33% premium over the $9B Series B. This premium is driven by continued ARR growth (Cursor was tracking to reach $1B ARR by end of 2026) and scarcity — the small team means fewer sellers and high institutional buyer demand.
Risk factors for Cursor equity
Cursor's equity profile has the highest concentration risk of any company in PrivatePulse's coverage. The company is entirely dependent on one product (the IDE) and one category (AI-assisted coding). Microsoft (VS Code's creator), GitHub (Copilot), and JetBrains (AI Assistant) are all potential competitive threats from better-resourced companies. A shift in developer tooling preferences could compress revenue quickly.
The ISO situation for early Cursor employees
Cursor grants ISOs. Early employees with grant-date strike prices in the $0.50–$3.00 range are sitting on dramatic in-the-money positions. At a $12B secondary valuation, even a 0.01% ownership stake represents $1.2M. Exercising these ISOs to start the holding period clock — while the spread is enormous but before a potential IPO — is a complex decision requiring CPA guidance.
Cursor is the ultimate high-concentration, high-upside equity story. If you're joining at the current $9B+ valuation, you're getting grants at a very different price point than early employees — but you're still getting exposure to a company growing 5× YoY with extraordinary unit economics.